CYLEMBIO Trademark

Trademark Overview

On Tuesday, February 6, 2024, a trademark application was filed for CYLEMBIO with the United States Patent and Trademark Office. The USPTO has given the CYLEMBIO trademark a serial number of 98394985. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, February 9, 2024. This trademark is owned by IO Biotech ApS. The CYLEMBIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines
cylembio

General Information

Serial Number98394985
Word MarkCYLEMBIO
Filing DateTuesday, February 6, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, February 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the stylized wording CYLEMBIO in blue with a circle made up of ten circles of varying sizes in varying shades of blue and purple in a circular pattern above the letter "I".
Goods and ServicesPharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines
Indication of Colors claimedThe color(s) blue and purple is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIO Biotech ApS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCopenhagen N DK-2200
DK

Trademark Events

Event DateEvent Description
Friday, March 15, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 9, 2024NEW APPLICATION ENTERED

Related Keywords

cylembio gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric related diseases system